Clinical Trial Update: Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for subcutaneous apomorphine infusion in advanced Parkinson's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Apomorphine (apomorphine)

Snippet

Sponsor: Britannia Pharmaceuticals Ltd. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2019-07-08